CSIR-CDRI Lucknow: Phase-III trials of ‘Picroliv’ drug against Fatty Liver to initiate soon
The CSIR-Central Drug Research Institute in Lucknow has developed a standardised drug 'Picroliv' against Non-Alcoholic Fatty Liver Disease (NAFLD) and ...
Tag: ~rmsc:rebelmouse-image:29431863
